Brian Mulherin in Noblesville, Indiana

Home Indiana Noblesville

Brian Mulherin has Hematology/oncology as his primary medical specialty. Their primary office is: 395 Westfield Rd in Noblesville, Indiana. There are 2 additional office locations for Brian Mulherin that can be viewed towards the end of their profile.

They're a part of the: American Oncology Partners Pa medical group which has around 188 members. You can call their office at 317-770-1184 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Loyola University Of Chicago, Stritch School Of Medicine and graduated in 2006 (around 18 years of experience). They are listed as doing telehealth appointments.

Brian P Mulherin Office Phone and Directions

Brian Mulherin
American Oncology Partners Pa
395 Westfield Rd
Noblesville, Indiana 46060
317-770-1184

Patient Ratings
Please rate your experience with Brian Mulherin below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 317-770-1184

Enter a starting address:

Healthcare Info for Brian Mulherin

Medical School: Loyola University Of Chicago, Stritch School Of Medicine
Graduation Year: 2006
The Primary Medical Specialty for Brian Mulherin is listed as: Hematology/oncology
Approximate Years of Experience: 18
PAC (PECOS ID)#: 5496929077
NPI #: 1922034156
NPI Created On: 06/22/2006
NPI Last Updated Listed as: 12/30/2022
Primary Taxonomy Code: 207RX0202X
License Number:
01066750A
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Celtic Insurance Company
Humana
CareSource
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

Insertion of needle into vein for collection of blood sample
Bone marrow biopsy and aspiration
Complete blood cell count (red cells, white blood cell, platelets), automated test
Red blood count, manual test
Hydration infusion into a vein 31 minutes to 1 hour
Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
Injection of different drug or substance into a vein for therapy, diagnosis, or prevention
Infusion of chemotherapy into a vein up to 1 hour
Infusion of chemotherapy into a vein
Infusion of different chemotherapy drug or substance into a vein up to 1 hour
New patient office or other outpatient visit, typically 45 minutes
New patient office or other outpatient visit, typically 60 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 40 minutes
Established patient office or other outpatient, visit typically 40 minutes

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $26

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788822487

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05

Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781013229

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $303

Number of Payments:: 1